NFE2L2 and Alzheimer disease: The interplay between Aβ and Nrf2 is highlighted by our finding that treatment of cells with Aβ resulted in increased expression of the Nrf2 target gene HO-1 in astrocytes, in line with previous studies [84] and reported increases in HO-1 expression in the AD brain [85].